499 related articles for article (PubMed ID: 17850853)
1. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
[TBL] [Abstract][Full Text] [Related]
2. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma.
Madom LM; Brown AK; Lui F; Moore RG; Granai CO; Disilvestro PA
Gynecol Oncol; 2007 Oct; 107(1):75-8. PubMed ID: 17629550
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
[TBL] [Abstract][Full Text] [Related]
5. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
6. Use of the sentinel node procedure to stage endometrial cancer.
Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
[TBL] [Abstract][Full Text] [Related]
7. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
8. Predictors of lymphatic failure in endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
Gynecol Oncol; 2002 Mar; 84(3):437-42. PubMed ID: 11855884
[TBL] [Abstract][Full Text] [Related]
9. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
[TBL] [Abstract][Full Text] [Related]
10. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
12. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
13. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
14. Predicting pelvic lymph node metastasis in endometrial carcinoma.
Kamura T; Yahata H; Shigematsu T; Ogawa S; Amada S; Kaku T; Nakano H
Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
[TBL] [Abstract][Full Text] [Related]
15. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
16. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
17. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion.
Takeshima N; Hirai Y; Tanaka N; Yamawaki T; Yamauchi K; Hasumi K
Obstet Gynecol; 1996 Aug; 88(2):280-2. PubMed ID: 8692516
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
19. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
20. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy.
Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M
Breast J; 2008; 14(3):245-9. PubMed ID: 18433402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
